feed,title,long_url,short_url
TheStreet,Vir Biotech Higher on Phase 3 Progress With COVID Antibody Drug,https://www.thestreet.com/investing/vir-biotech-shares-higher-on-progress-with-covid-antibody-treatment,https://j.mp/3bzEUog
